Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
16(84.2%)
Phase 2
2(10.5%)
Phase 3
1(5.3%)
19Total
N/A(16)
Phase 2(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT06816485Not ApplicableRecruiting

INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis

Role: lead

NCT05505929Recruiting

eUltra 10k - Biofreedom Ultra

Role: lead

NCT05643430Not ApplicableActive Not Recruiting

ULTRA LONG: BioFreedom Ultra

Role: lead

NCT06657326Not ApplicableRecruiting

LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients

Role: lead

NCT05799963Not ApplicableActive Not Recruiting

ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD

Role: lead

NCT03609346Completed

Asian Registry of the BioFreedom Stent for STEMI Patients

Role: lead

NCT03118895Not ApplicableCompleted

Leaders Free III: BioFreedom™ Clinical Trial

Role: lead

NCT04796038Not ApplicableCompleted

Rise Semi Compliant Balloon Study in Patient With CAD

Role: lead

NCT04966273Not ApplicableCompleted

Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO) - BIOMICS

Role: lead

NCT04079192Not ApplicableUnknown

Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study

Role: lead

NCT03745066Unknown

BioFreedom French Registry

Role: lead

NCT02843633Not ApplicableActive Not Recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Role: lead

NCT03073447Not ApplicableCompleted

WAMIF : Young Women Presenting Acute Myocardial Infarction in France

Role: collaborator

NCT03365492Not ApplicableCompleted

BioFreedom Pharmacokinetic Study

Role: lead

NCT03461484Completed

e-BioMatrix 6 Month DAPT France

Role: lead

NCT03307213Not ApplicableUnknown

BioFreedom QCA Study in CAD Patients

Role: lead

NCT00389220Not ApplicableCompleted

Limus Eluted From A Durable Versus ERodable Stent Coating

Role: lead

NCT01915628Completed

e-BioMatrix Canada Registry

Role: lead

NCT01289002Completed

e-BioMatrix PostMarket Registry

Role: lead

NCT01254487Completed

e-BioMatrix PostMarket Surveillance Registry

Role: lead